Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy

Published:2018-02 Issue:2 Volume:41 Page:53-63
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Furusawa Aki,Reiser John,Sadashivaiah Kavitha,Simpson Haley,Banerjee Arnob

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference75 articles.

1. The three main stumbling blocks for anticancer T cells;Baitsch;Trends Immunol,2012

2. Engineered T cells: the promise and challenges of cancer immunotherapy;Fesnak;Nat Rev Cancer,2016

3. Long-lasting complete responses in patients with metastatic melanoma after adoptive cell therapy with tumor-infiltrating lymphocytes and an attenuated IL2 regimen;Andersen;Clin Cancer Res,2016

4. Exploiting the curative potential of adoptive T-cell therapy for cancer;Hinrichs;Immunol Rev,2014

5. Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook;Wu;Cancer J,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and validation of prognostic signature for transcription factors regulating T cell exhaustion in hepatocellular carcinoma;Medicine;2024-07-05

2. Identification of characteristic genes and construction of regulatory network in gallbladder carcinoma;BMC Medical Genomics;2023-10-11

3. Application of weighted gene co-expression network analysis to explore potential prognostic markers of head and neck squamous cell carcinoma;2022-11-04

4. EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia;Leukemia;2021-03-17

5. PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma;OncoImmunology;2019-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3